Video

Greg Stephens Offers Advice for the Newly Diagnosed CML Patient

One of the reoccurring themes at the 56th Annual Meeting of the American Society of Hematology was the importance of proper monitoring, said Greg Stephens, executive director of the National CML Society.

One of the reoccurring themes at the 56th Annual Meeting of the American Society of Hematology was the importance of proper monitoring, said Greg Stephens, executive director of the National CML Society.

When patients stay on their therapy and are monitored closely, providers can see any red flags and know when to change therapy or make adjustments, he said.

“What we know is that proper monitoring in the CML space is critical and not only for the health of the patients but also for their financial wellbeing and the wellbeing of the insurance companies that have to pay for these drugs,” Mr Stephens said.

Related Videos
Susan Escudier, MD, FACP
Screenshot of an interview with Evangelia Vlachou, MD
Screenshot of an interview with Barry Goy, MD
Debra Patt, MD, PhD, MBA, MPH
Clayton Irvine, PharmD, MBA, MS.
Debra Patt, MD, PhD, MBA, MPH
Debra Patt, MD, PhD, MBA, MPH
Chelsee Jensen, PharmD, BCPS.
Kara Kelly, MD, chair of pediatrics, Roswell Park Oishei Children's Cancer and Blood Disorders Program
Sandra Cuellar, PharmD
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo